Created in 2005 (Germany), BETAFERON INTERFERON BETA-1b Early strength, lasting benefit. own 2081 sister brands and 17477 competing brands. The BETAFERON INTERFERON BETA-1b Early strength, lasting benefit. brand is owned by BAYER, a company listed in Francfort. The ISIN, the company's International Securities Identification Number, is DE000BAY0017. The sector of BETAFERON INTERFERON BETA-1b Early strength, lasting benefit. is Drug Manufacturers.

BETAFERON INTERFERON BETA-1b Early strength, lasting benefit. is a brand of BAYER (BAYN) Share price

International deposit : 2005 Business sector Drug Manufacturers

Share price and profitability of the share BAYER (BETAFERON INTERFERON BETA-1b Early strength, lasting benefit.)

Buy BAYER share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested EUR 27.00

Portfolio valuation
BAYER (BETAFERON INTERFERON BETA-1b Early strength, lasting benefit.) over 5 years* EUR 12.10

Stock market history BAYER (BETAFERON INTERFERON BETA-1b Early strength, lasting benefit.)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
BAYER

Vividion Therapeutics
Vividion Therapeutics
Care/of
Care/of
Synpromics
Synpromics
RoverMed
RoverMed
BRAINVECTIS
BRAINVECTIS
ASKBIO
ASKBIO
See more brands of BAYER

Rival brands
BETAFERON INTERFERON BETA-1b Early strength, lasting benefit.

POINT BIOPHARMA
POINT BIOPHARMA
Icosavax
Icosavax
OGX
OGX
MAUI MOISTURE
MAUI MOISTURE
POLYSPORIN
POLYSPORIN
LACTAID
LACTAID
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands > Pricing Power > 5 major sectors
Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS